{"id":1191,"date":"2019-12-27T17:16:15","date_gmt":"2019-12-27T17:16:15","guid":{"rendered":"https:\/\/wiharper.com\/?p=1191"},"modified":"2019-12-27T17:16:15","modified_gmt":"2019-12-27T17:16:15","slug":"wi-harper-group-was-recognized-as-top-10-vc-firms-in-digital-health-by-vcbeat","status":"publish","type":"post","link":"https:\/\/wiharper.com\/wi-harper-group-was-recognized-as-top-10-vc-firms-in-digital-health-by-vcbeat\/","title":{"rendered":"WI Harper Group was recognized as “Top 10 VC Firms in Digital Health” by VCBeat"},"content":{"rendered":"\n

WI\nHarper Group<\/a> | December 23, 2019<\/em><\/p>\n\n\n\n

<\/div>\n\n\n\n

Recently, the 2019 Future Healthcare VB 100 Conference<\/em> was held in Beijing, with\nthe theme \u201cNew Increment of Life\u201d.  The\nconference is focused on the current and future state of China\u2019s healthcare\nindustry with a strong emphasis on policy and innovation trends.  During the event, WI Harper Group was recognized as one of the “Top 10 VC Firms in Digital\nHealth\u201d, <\/strong>alongside other renowned VC firms.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n
<\/div>\n\n\n\n

Launched by healthcare-focused VCBeat and VCBeat Research\n(VBR) in 2015, the Top 100 Future Healthcare (VB100) is a list of innovative\nmedical and health private enterprises. \nThe goal of the VB100 is to recognize leading companies in China that\nrepresent the advancement of medical treatment and promote healthcare industry\nreform.  <\/p>\n\n\n\n

<\/div>\n\n\n\n

The 2019 VB100 covers four major healthcare fields of (1)\nmedical service, (2) innovative medical equipment, (3) digital medicine, and\n(4) innovative medicine.  It also covers\ndozens of subdivisions such as the third-party medical imaging center, mental\nhealth, electronic medical record, surgical robotics, and rehabilitation\nequipment.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n
<\/div>\n\n\n\n

Founded in 1993, WI Harper is a pioneering cross-border\nventure capital firm investing in early to growth-stage companies across the\nUS, Greater China, and the Asia Pacific. We have invested in more than 400\ncompanies that significantly advance \u2013 or even reinvent the wheel \u2013 the fields\nof healthcare, biotech, artificial intelligence (AI), robotics, fin-tech,\nsustainability, and new media.  <\/p>\n\n\n\n

<\/div>\n\n\n\n

In the field of healthcare, WI Harper Group primarily focuses\non digital medicine, innovative biotechnological drugs, medical devices, and\nmedical services. The company also focuses on the interdisciplinary\nintersection of healthcare and other technologies, such as combinations of\nhealthcare and AI, blockchain, 5G, and other new technologies. WI Harper has\ninvested in and successfully exited from iKang, MedicalSystem, Edan, CAVID, and\nmany more. WI Harper has currently invested in leading start-up companies such\nas EdiGene, Synthego, XW Laboratories, Resvent, Labtech, Panorama Medicine,\nIIPharma, Enginebio, DeepBiome, Histo, Neuracle, Amwise Diagnostics, and many\nmore. This award is a strong affirmation of WI Harper Group\u2019s investment\nstrategy and leading industry recognition.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n
<\/div>\n\n\n\n

| Related investment enterprises of WI Harper<\/strong><\/p>\n\n\n\n

<\/div>\n\n\n\n

MedicalSystem<\/strong><\/p>\n\n\n\n

MedicalSystem\n(Ticker CH 603990) is the leading Hospital Informatics company in China,\ncurrently specializing in providing Anesthesia Information Management Systems\nand Intensive Care Unit \/ Coronary Care Unit Information Management Systems.\nThe company provides full life-cycle management throughout the intensive care\n(first aid, emergency, critical, surgery, specialized center).<\/p>\n\n\n\n

<\/div>\n\n\n\n

Histo\nPathology <\/strong><\/p>\n\n\n\n

Histo is\nthe first 3rd<\/sup> party outsourced pathology diagnosis center to be\nlicensed in China. It is also the country\u2019s largest dedicated pathological\ndiagnosis institution.  It has over 300 collaborative\nmedical institutions and the largest hospitals coverage rate in Eastern China.\nHisto actively applies advanced IT to the pathology industry, establishes\nremote consultation platforms for difficult medical problems, develops AI\nauxiliary diagnosis system, and enables basic medical treatment.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Panorama\nMedicine<\/strong><\/p>\n\n\n\n

Panorama\nMedicine is a VC-backed startup founded by a multidisciplinary team of\nworld-renowned computational and experimental RNA biologists. The company has\nleveraged the founding team\u2019s expertise to create a drug discovery platform\nthat integrates genomics, big data, and computing to develop therapeutic\ninterventions (RNA Splicing) for RNA defects in disease.<\/p>\n\n\n\n

<\/div>\n\n\n\n

IIPharma<\/strong><\/p>\n\n\n\n

IIPharma\nis a start-up that utilizes advanced AI technologies towards innovative drug\ndiscovery.   The company offers Intelligent\nPharma Brain<\/em><\/strong>\u2122, which is a proprietary AI + new drug R&D\nplatform.<\/p>\n\n\n\n

<\/div>\n\n\n\n

DeepBiome<\/strong><\/p>\n\n\n\n

DeepBiome\nis an AI computational drug discovery company that was spun out from Harvard\nand the MIT Broad Institute.  The company\nis focused on the highly promising and cutting-edge field of the human\nmicrobiome, a largely untapped treasure trove for drug leads discovery.\nDeepBiome aspires to revolutionize the currently costly and inefficient drug\ndiscovery process by utilizing the latest artificial learning.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Enginebio<\/strong><\/p>\n\n\n\n

Enginebio\nwas founded by Tim Lu, a scientist at the world’s leading MIT Broad Research\nInstitute. The company has proprietary and patented technologies oriented\naround deciphering the complexity of biology networks, including both\nhigh-throughput wet-lab experimentation and AI algorithms for drug discovery\nand cellular reprogramming. <\/p>\n\n\n\n

<\/div>\n\n\n\n

Translated\nfrom: https:\/\/mp.weixin.qq.com\/s\/jclLiDWIq1rHHR3bzZu_9Q<\/a>\n<\/p>\n","protected":false},"excerpt":{"rendered":"

WI Harper Group | December 23, 2019 Recently, […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"blocksy_meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/posts\/1191"}],"collection":[{"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/comments?post=1191"}],"version-history":[{"count":0,"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/posts\/1191\/revisions"}],"wp:attachment":[{"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/media?parent=1191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/categories?post=1191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wiharper.com\/wp-json\/wp\/v2\/tags?post=1191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}